Iran VAT and the Annual Budget Rate for Medical Device Businesses

1. Key takeaways

The statutory standard rate under Iran’s Value Added Tax Law is 9%, but the rate can be raised year by year through the annual budget law, and public industry sources indicate that the applied rate in recent years has been in the region of 10%. GRZAN’s assessment is that this is the variable most easily overlooked on an Iranian quotation — pricing the current fiscal year using the previous fiscal year’s rate directly erodes gross margin. The correct approach is to re-verify the rate set by the current year’s budget law in every fiscal year, which begins on 21 March. Because the adjustment happens through a routine annual instrument rather than through an exceptional political event, it repeats reliably and must be built into the pricing calendar rather than handled ad hoc each time it surprises someone. A rate that moves every year through a predictable instrument is, for planning purposes, easier to manage than one that moves rarely but without warning, and that predictability is precisely what makes a scheduled annual verification effective.

2. Legal basis

1. Value Added Tax Law, approved on 23 May 2021 and in force from 3 January 2022; the standard rate is 9%, composed of 6% value added tax plus 3% municipal consumption tax; higher rates apply to specific goods (for example, imported raw tobacco 10%, oil and gas categories 15%, imported tobacco products 65%). The composition matters as much as the headline figure, because the two components are often reconciled separately with the local agent.
2. Institutional evolution: the Iranian National Tax Administration has raised the rate year by year under the authorisation of Article 117 of the Fifth Five-Year Development Plan Law, increasing it to 9% from the Iranian calendar year 1394 (from 21 March 2015) — see the Tax Guide for Chinese Residents Investing in Iran issued by the Chinese tax authorities. This history shows that the rate has been moved through delegated annual instruments for years, which is exactly the pattern companies should expect to continue.
3. Current applied rate: public industry sources indicate that the rate actually applied in recent years is around 10%, adjusted under authorisation of the annual budget law — this is a practical estimate, subject to the publication of the budget law for the year concerned. The applied figure must therefore be confirmed annually and never carried forward unchanged from the previous year.

3. Expert insights

Insight one: the separation between the statutory rate and the applied rate is a characteristic of the Iranian tax system. The Value Added Tax Law sets 9%, and the annual budget law can adjust it. This structure — the statute sets the baseline, the budget sets the applied level — requires companies to build an annual verification mechanism instead of settling the rate once and forgetting it, because the applied figure moves through a routine instrument that repeats every year and will not announce itself to a company that is not watching. Each verification should also produce a dated record of where the year’s figure came from, so the file can answer that question later without reconstruction.

Insight two: the composition of 6% plus 3% explains the split basis of the rate. The standard rate consists of the value added tax proper and the municipal consumption tax. When reconciling the tax burden with the local agent, companies should confirm that both components have been included, because quotations that capture only one of the two parts will understate the real burden even when the headline percentage looks correct on the face of the document.

Insight three: the zero rate for exports is a usable policy. Legally exported goods and services are subject to the zero rate, and tax already paid can be refunded under the prescribed procedure. For companies using Iran as a regional distribution hub, this policy has real value, since the same shipment structure that serves neighbouring markets also qualifies for relief on the Iranian side, provided the export is properly documented as such. The refund procedure rewards documentation discipline, which is the same discipline the annual rate verification already requires, so the two workstreams can share one documentation routine.

4. Practical recommendations

1. Verify the rate every fiscal year: check the applied rate set by the current year’s budget law from 21 March onwards, treating the verification as a scheduled task rather than a reaction to a surprise, and recording the source of each year’s figure in the compliance file.
2. Confirm the composition basis: check with the local agent that both the 6% and the 3% components are included in the quotation, so that the priced tax burden matches the real one and no component is silently omitted from the price to the customer.
3. Add a tax burden adjustment clause to contracts: agree a price adjustment mechanism for rate movements beyond an agreed threshold, so that statutory changes do not silently absorb margin and neither party has to renegotiate from scratch each time the rate moves, with the threshold defined explicitly so the clause can be applied without interpretation.
4. Assess the export zero rate policy: companies using Iran as a regional distribution hub should evaluate the feasibility of refunds, since the policy rewards exactly that structure and the refund procedure has its own documentation requirements worth preparing for in advance.

5. Verification checklist

• □ The applied VAT rate for the current fiscal year (from 21 March) has been verified
• □ Quotations have been confirmed to include both the 6% and the 3% components
• □ Contracts contain a price adjustment clause for tax burden changes
• □ The export zero rate and refund policy have been assessed
• □ Tax verification has been included in the annual compliance calendar

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Iranian market. Our team manages adverse event reporting and recall coordination with IFDA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com